Inspire Medical Systems said yesterday that it won a positive coverage policy for its Inspire therapy, intended to treat obstructive sleep apnea, from insurer Blue Cross of Idaho. The Minneapolis-based company’s Inspire system is a closed-loop, pacemaker-like system designed to stimulate nerves to keep airways open during sleep to treat obstructive sleep apnea. The coverage […]
Inspire Medical Systems scores win with Blue Cross Blue Shield Association
Inspire Medical Systems – creator of a pacemaker-like system to treat obstructive sleep apnea – said today that the Blue Cross Blue Shield Association’s Evidence Street issued a positive assessment of Inspire therapy to its members. BCBSA is a national federation of 36 Blue Cross and Blue Shield companies. The report from BCBSA, according to Inspire […]
Inspire Medical Systems closes $75m offering
Inspire Medical Systems said yesterday that it closed a $75 million offering, which included a fully exercised underwriter’s option. The Minneapolis-based company said that it floated 2.5 million shares of common stock, with 1.5 million offered by Inspire itself and 1 million offered by certain shareholders. The round also included 375,000 shares offered through a fully […]
Inspire Medical offers another 1.5 million shares following April IPO
Inspire Medical Systems (NYSE: INSP) is offering 1.5 million shares of common stock for sale to the public, and its stockholders are selling 1 million additional shares of the stock, according to a regulatory filing. The company hopes to make $66.8 million on the sale. Maple Grove, Minn.-based Inspire, which spun out from Medtronic (NYSE:MDT) in 2007, makes devices […]
Japan approves Inspire Medical’s obstructive sleep apnea neurostim device
Inspire Medical Systems said this week it won approval from Japan’s Ministry of Health, Labour and Welfare for its Inspire therapy system, now cleared to treat moderate to severe obstructive sleep apnea. The Inspire system is a closed-loop, pacemaker-like system designed to stimulate nerves to keep airways open during sleep to treat obstructive sleep apnea. […]
Inspire Medical prices up-sized $108m IPO
Inspire Medical Systems yesterday up-sized its initial public offering to $108 million, or some $124 million if the underwriters option is exercised in full. Maple Grove, Minn.-based Inspire, which spun out from Medtronic (NYSE:MDT) in 2007, makes devices for treating obstructive sleep apnea. The company had said it planned to issue 5 million shares at $14 to $16 apiece, […]
Medtronic spinout Inspire Medical sets range for $75m IPO
Inspire Medical Systems this week set the range for a proposed initial public offering that would fetch $75 million at the midpoint. Maple Grove, Minn.-based Inspire, which spun out from Medtronic (NYSE:MDT) in 2007, makes devices for treating obstructive sleep apnea. The company said it plans to issue 5 million shares at $14 to $16 apiece, setting its […]
Inspire Medical plans $86m IPO
Inspire Medical Systems, which spun out from Medtronic (NYSE:MDT) in 2007 and creates devices for treating obstructive sleep apnea, said last Friday it is looking to launch an initial public offering that could bring in as much as $86.3 million for the company. Inspire Medical developed and produces a sleep apnea implant, a pacemaker-like system designed to […]
Medtronic spinout Inspire Medical closes $38m Series F
Inspire Medical Systems, which spun out from Medtronic (NYSE:MDT) in 2007, said yesterday it closed a $37.5 million Series F financing round, as well as announcing the appointment of Marilyn Nelson to the board of directors. Inspire Medical developed and produces a sleep apnea implant, a pacemaker-like system designed to stimulate nerves to keep airways […]
Inspire Medical Systems raises $13m for sleep apnea device
Inspire Medical Systems has raised $12.5 million in a new round of equity financing, according to an SEC filing posted today. Inspire Medical developed and produces a sleep apnea implant, a pacemaker-like system designed to stimulate nerves to keep airways open during sleep. Good sleep is necessary for cpap and can affect hormone levels, mood […]
Medtech investment hits 6-year high in Minnesota
Investment in Minnesota’s thriving medtech scene hit a 6-year high in 2014 and the state saw a significant jump in pharma/biotech investments, according to LifeScience Alley’s annual report.
MassDevice Network
@MassDevice
LinkedIn
YouTube